期刊文献+

乳腺浸润性微乳头状癌的临床研究 被引量:3

Clinical research of invasive micropapillary carcinoma of breast
暂未订购
导出
摘要 目的研究乳腺浸润性微乳头状癌的临床特点。方法回顾分析我院2007年1月~2011年7月共581例浸润性导管癌患者资料,其中18例乳腺浸润性微乳头状癌,进行临床资料和病理资料的分析研究。结果乳腺浸润性微乳头状癌占乳腺浸润性导管癌的3.1%,患者平均年龄53.2岁,无特殊的主诉、病史和体检,B超一般提示为低回声结节或实性占位,肿块多有丰富彩色血流信号(9/10)。钼靶BI-RADS分级高I,V级以上的有15例(15/18)。均行乳腺癌改良根治术,有脉管浸润的有10例,占55.6%。伴有同侧腋窝淋巴结转移的有13例,占72.2%;术后病理分期I,期的有5例I,I期的有4例I,II期的有9例。术后根据病理情况行化放疗和内分泌治疗。随访16例,时间2~45个月,均未发现复发和远处转移。结论乳腺浸润性微乳头状癌无特殊的临床表现和影像学表现,但B超和钼靶多有恶性表现。乳腺浸润性微乳头状癌具有高的淋巴结转移率和术后病理分期,术后适当的综合治疗可能延长患者的无病生存期。 Objective To research the clinical characteristics of invasive micropapillary carcinoma(IMPC) of breast.Methods 581 cases were selected from January 2007 to July 2011 in our hospital.18 of them were IMPC.Their clinical materials were analyzed and studied.Results The occurrence of IMPC was 3.1%.The average age was 53.2 years without special clinical characteristics.In terms of sonography,the common findings were of hypoechoic nodules or mass with abundant bloodstream wink(9/10).Mammography imaging of IMPC had high grade BI-RADS and 15 cases(15/18) exceeded grade IV.The incidence of metastases of the lymph node was 72.2%(13/18),(mean 6.2).There were 5 cases of stage I,4 cases of stage II and 9 cases of stage Ⅲ.Follow-up was available in 16 patients.Everyone was alive without local recurrences and distant metastases.Conclusion IMPC has no exceptional clinical manifestation and imaging characteristics.But mammography imaging characteristics of IMPC were high suggestive of malignancy with high grade BI-RADS.IMPC has high incidence of metastases of the lymph node and late pathological stage.Properly comprehensive treatment after operation would do good to prolong the free survival of patients.
出处 《淮海医药》 CAS 2012年第2期119-120,共2页 Journal of Huaihai Medicine
关键词 乳腺肿瘤 浸润性微乳头状癌 免疫组织化学 Breast neoplasm Invasive micropapillary carcinoma Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献17

  • 1范宇,郎荣刚,王颖,孙保存,付丽.乳腺浸润性微乳头状癌上皮性钙黏附素的表达及意义[J].中华病理学杂志,2004,33(4):308-311. 被引量:41
  • 2付丽.乳腺的浸润性癌[A].付丽 主编.乳腺疾病彩色图谱[C].北京:人民卫生出版社,2001.63-113.
  • 3许良中.浸润性微乳头状癌[A].许良中 主编.乳腺病理学[C].上海:上海医科大学出版社,1999.186.
  • 4Fisher ER, Palekar AS, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Projet (protocol no. 4 ). Ⅵ.Invasive papillary cancer. Am J Clin Pathol, 1980, 73: 313-322.
  • 5Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol,1993 ,6 :660-662.
  • 6Luna-More S, Gonzalez B, Acedo C, et al. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol Res Pract, 1994,190:668-674.
  • 7Middelton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol, 1999, 12: 499-504.
  • 8Luna-More S, de los Santos F, Breton J J, et al. Estrogen and progesterone receptor, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micorpapillary breast carcinomas. Pathol Res Pract, 1996,192:27-32
  • 9Luna-More S, Casquero S, Perez-Mellabo A, et al. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow -up of 54.Pathol Res Pract, 2000,196:35-39.
  • 10Tsumagari K, Sakamot G, Akiyama F, et al. The clinico pathological study of invasive micropapillary carcinoma of the breast.Jpn J Breast Cancer, 2001,16:341-348.

共引文献107

同被引文献27

  • 1付丽.重视乳腺浸润性微乳头状癌的诊断[J].中华病理学杂志,2004,33(4):305-307. 被引量:26
  • 2郭晓静,陈凌,郎荣刚,范宇,付丽.乳腺浸润性微乳头状癌的病理学特征与淋巴结转移的关系[J].中华病理学杂志,2006,35(1):8-12. 被引量:34
  • 3Lkhani SR, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumors of the Breast[M]. IARC: Lyon, 2012 : 65-66.
  • 4UICC. TNM classification of malignant tumors[M]. 6th ed. Hoboken : John Wiley & Sons, 2002 : 131-142.
  • 5Luna-More S, Gonzalez B, Aeedo C, et al. Invasive micropapillary carcinoma of the breast: a new special type of invasive mammary carcinoma [J]. Pathol Res Pratt, 1994, 190 (7) :668-674.
  • 6Pettinato G, Manivel C J, Panieo L, et al. Invasive micropapillary carcinoma of the breast: clinicopathologieal study of 62 cases of a poorly recognized variant with highly aggressive behavior[J]. Am J Clin Pathol,2004,121(6) :857-866.
  • 7Yu JI, Choi DH, Park W, et al. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study[J]. Breast,2010,19(3) :231 -237.
  • 8Shigematsu H, Nakamura Y, Tanaka K, et al. A case of Her- 2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paelitaxel treatment [J]. Int J ClinOncol,2010,15(6):615-620.
  • 9Alvarado-Cabrera I, Alderete-Vdzquez G. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her-2/Neu, and gross pathologic findings[J]. Ann Diagn Pathol, 2009,13 (3) :151-157.
  • 10李晨,王勇,杨裕辉,高玉丽,赵忻.高频彩色多普勒超声检查乳腺导管内乳头状瘤的价值[J].实用医技杂志,2009,16(2):90-92. 被引量:7

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部